jueves, 24 de septiembre de 2026 | About usContactSubmit a report
JUSTICIA contenido monitoreado

Luigi Mangione Pleads Guilty to Murdering UnitedHealthcare CEO Brian Thompson

Mangione admits to the fatal shooting during a court appearance, facing life imprisonment.

Luigi Mangione Pleads Guilty to Murdering UnitedHealthcare CEO Brian Thompson
Listen to article3 min approx. · Choose a language to play

Luigi Mangione, 28, entered a guilty plea in a federal court in Manhattan on Friday, admitting to the murder of Brian Thompson, the CEO of UnitedHealthcare, outside a Midtown hotel in December 2024. This plea comes as Mangione faces both federal and state trials for the shooting.

Details of the Court Appearance

During the court session, which began shortly after 11 a.m., Mangione appeared shackled and dressed in prison attire. His defense team informed the judge that he was ready to plead guilty to the indictment. The judge confirmed Mangione’s competency to enter the plea and explained the potential consequences, including a maximum sentence of life in prison without the possibility of parole.

Admission of Guilt

In his statement to the court, Mangione recounted his long-standing pain from a broken back and his frustrations with the health insurance system. He disclosed that he had learned about an annual investor conference hosted by UnitedHealthcare and had posed as an investor to gain access. Mangione admitted to traveling to New York with a 3D-printed gun, silencer, and magazine, stating, «On the morning of December 4, 2024, I shot Mr. Thompson in Manhattan and he died.» He acknowledged understanding the gravity of his actions and their illegality.

Prosecution’s Evidence

Prosecutors presented substantial evidence against Mangione, including surveillance footage of the shooting, his escape on a bicycle, and DNA found at the crime scene. They also referenced his notebook, which contained entries expressing a desire to kill a healthcare executive. Initially, Mangione faced four federal charges, including one that could have led to the death penalty, but two charges were dismissed earlier this year.

State Trial and Double Jeopardy Concerns

While Mangione awaits sentencing in the federal case, his state trial is scheduled to begin in September. His defense attorney has filed a motion to dismiss state charges based on New York’s double jeopardy law, which prohibits a person from being prosecuted twice for the same offense. The Manhattan District Attorney’s office has stated its intention to contest this motion, emphasizing their commitment to pursuing justice for Thompson’s family.

Reactions from Thompson’s Family and Officials

Thompson’s family expressed their gratitude for the accountability achieved through the federal justice system, stating, «While nothing will ease the pain of losing him, we are grateful that the federal justice system has held the person responsible for this heinous act accountable.» UnitedHealthcare also released a statement mourning Thompson’s loss and commending law enforcement for their efforts.

Legal Perspectives

Legal experts have noted that the plea could potentially influence the state case, as Mangione’s legal team hopes to leverage the guilty plea to dismiss state charges. The complexities of double jeopardy laws in New York may play a significant role in the upcoming proceedings.

Conclusion

As the legal battles continue, Mangione’s case highlights the intersection of mental health, legal accountability, and the consequences of violent actions. With sentencing scheduled for December 18, the implications of his plea will unfold in the coming months.

CBS News - Top Stories Fuente informativa: CBS News - Top Stories

¿Tienes información relacionada?

Puedes enviarnos información de forma anónima. Nuestro equipo la revisará antes de publicarla.

SUBMIT A REPORT

Deja una respuesta

Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *

SUSCRÍBETE A NUESTRO BOLETÍN

Recibe las noticias más importantes de tu región e investigaciones exclusivas directamente en tu correo.